What UroGen Pharma Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 15 |
| Total trades | 6 | 32 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 32 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Robinson James A. Jr. | Director | Aug 26 | Exercise / conversion · M | +2,000 | — | — | 8,000 |
| Schoenberg Mark | Chief Medical Officer | Aug 20 | Open-market sale · S | −60,677 | $47.05 | −$2.85M | 59,086 |
| Schoenberg Mark | Chief Medical Officer | Jul 09 | Open-market sale · S | −10,000 | $40.00 | −$400K | 119,763 |
| Schoenberg Mark | Chief Medical Officer | Jun 22 | Open-market sale · S | −10,000 | $35.01 | −$350K | 129,763 |
| Schoenberg Mark | Chief Medical Officer | Jun 08 | Sale for tax withholding · S | −5,222 | $27.30 | −$143K | 139,763 |
| Schoenberg Mark | Chief Medical Officer | Jun 08 | Exercise / conversion · M | +10,000 | — | — | 144,985 |
| Robinson James A. Jr. | Director | May 26 | Exercise / conversion · M | +2,000 | — | — | 6,000 |
| Schoenberg Mark | Chief Medical Officer | May 08 | Open-market sale · S | −10,000 | $30.00 | −$300K | 134,985 |
| Smith Jason Drew | General Counsel | Feb 03 | Sale for tax withholding · S | −3,217 | $19.69 | −$63.3K | 55,588 |
| Smith Jason Drew | General Counsel | Feb 03 | Sale for tax withholding · S | −1,608 | $19.69 | −$31.7K | 51,326 |
| Smith Jason Drew | General Counsel | Feb 03 | Sale for tax withholding · S | −2,654 | $19.69 | −$52.3K | 52,934 |
| Schoenberg Mark | Chief Medical Officer | Feb 03 | Sale for tax withholding · S | −3,686 | $19.69 | −$72.6K | 144,985 |
| Schoenberg Mark | Chief Medical Officer | Feb 03 | Sale for tax withholding · S | −1,843 | $19.69 | −$36.3K | 148,671 |
| Schoenberg Mark | Chief Medical Officer | Feb 03 | Sale for tax withholding · S | −1,844 | $19.69 | −$36.3K | 150,514 |
| Smith Jason Drew | General Counsel | Jan 31 | Exercise / conversion · M | +6,667 | — | — | 49,972 |
| Smith Jason Drew | General Counsel | Jan 31 | Exercise / conversion · M | +3,333 | — | — | 58,805 |
| Smith Jason Drew | General Counsel | Jan 31 | Exercise / conversion · M | +5,500 | — | — | 55,472 |
| Schoenberg Mark | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +3,334 | — | — | 142,359 |
| Schoenberg Mark | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +6,666 | — | — | 152,358 |
| Schoenberg Mark | Chief Medical Officer | Jan 31 | Exercise / conversion · M | +3,333 | — | — | 145,692 |
Loading...